Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease-Reference-Cited by-同舟云学术

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

Published:1999-07 Issue:1 Volume:117 Page:58-64
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sands Bruce E.,Bank Simmy,Sninsky Charles A.,Robinson Malcolm,Katz Seymour,Singleton John W.,Miner Philip B.,Safdi Michael A.,Galandiuk Susan,Hanauer Stephen B.,Varilek Gary W.,Buchman Alan L.,Rodgers Vance D.,Salzberg Bruce,Cai Bin,Loewy John,DeBruin Michael F.,Rogge Holly,Shapiro Mark,Schwertschlag Ullrich S.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease;Targan;N Engl J Med,1997

2. Interleukin-11: review of molecular, cell biology, and clinical use;Du;Blood,1997

3. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice;Neben;Blood,1993

4. A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy;Gordon;Blood,1996

5. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy;Tepler;Blood,1996

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IHH, SHH, and primary cilia mediate epithelial-stromal cross-talk during decidualization in mice;Science Signaling;2023-02-28

2. Frequency and risk factors of thromboembolic complications in patients with inflammatory bowel diseases;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2022-12-01

3. Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases;Terapevticheskii arkhiv;2022-02-15

4. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology;Nature Reviews Gastroenterology & Hepatology;2021-07-01

5. Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11;Frontiers in Immunology;2020-07-16